Advertisement

Search Results for "Oligosaccharides Bowel Syndrome"

07:40 EDT 22nd May 2013 | BioPortfolio

Original Source: Fructo-Oligosaccharides and Irritable Bowel Syndrome

Fructo-oligosaccharides are known as prebiotic ingredients to modulate the composition of the intestinal microbiota and particularly to stimulate the growth of Bifidobacteria. Imbalance of the intestinal microbiota such as reduction of Bifidobacteria is implicated in Irritable Bowel Syndrome (IBS). Thus the objective of the study is to evaluate the effect of fructo-oligosaccharides to improve IBS score and to explore which modifications of the microbiota are responsible of this...

Matching Channels

Short Bowel Syndrome

Irritable Bowel Syndrome IBS

Irritable bowel syndrome (IBS) is a common but poorly understood chronic (long-term) condition where the normal functions of the bowel are disrupted. Symptoms of IBS include abdominal pain or discom...

Inflammatory Bowel Disease IBD

Bladder and bowel function

Colorectal Cancer

Colon or Colorectal cancer is the growth of malignant polyps on the colon, bowel, anus and rectum. Growths in these locations can be benign, and removed by colonoscopy, but they have a risk of becom...

Matching News

Debunking Myths about Peak Area Response of Glycoprotein Oligosaccharides

Thermo Fisher Scientific has released a technical note (TN) that challenges the common misconception that there is significant variation in high-performance anion-exchange chromatography with pulsed a...

Studying The Causes Of Irritable Bowel Syndrome - GENIEUR

Experts and scientists from 19 European countries are getting together to investigate the causes of IBS (irritable bowel syndrome) with the aim of better understanding the condition and improving diag...

Health Tip: Keep Irritable Bowel Syndrome in Check

-- Irritable bowel syndrome can trigger cramps, abdominal pain, diarrhea and gas. But the cause is unclear, and an examination of the colon usually turns up no signs of the disease. The American Gastr...

Lynch Syndrome Gene Mutation Discovered

Researchers have discovered a gene mutation responsible for an inherited form of bowel cancer, Lynch Syndrome.  Lynch Syndrome is an inherited form of bowel cancer responsible for up to 5% of c...

FDA approves NPS Pharma's bowel syndrome drug but with a rider

(Reuters) - U.S. health regulators approved NPS Pharmaceuticals Inc's short bowel syndrome drug Gattex, but asked the company to conduct a post-market study to evaluate cancer risks associated with th...

New drug might help treat irritable bowel syndrome

(HealthDay)—A new drug significantly reduces the abdominal pain and constipation characteristic of certain types of irritable bowel syndrome, according to two new studies.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) -- The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA approves Ironwood, Forest Labs bowel drug

The Food and Drug Administration on Thursday approved a new irritable bowel syndrome and constipation drug developed by Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc.The agency approved L...

Matching PubMed Articles

Guillain-Barre syndrome, tuberculosis and inflammatory bowel disease: a multiple association.

ABSTRACT: Guillain-Barre syndrome has been associated with both infective or non-infective aetiologies. Guillain-Barre syndrome is usually preceded by acute respiratory or gastrointestinal infection b...

Interstitial Cystitis/Painful Bladder Syndrome and Associated Medical Conditions With an Emphasis on Irritable Bowel Syndrome, Fibromyalgia and Chronic Fatigue Syndrome.

PURPOSE: We characterized and compared the impact of clinical phenotypic associations between interstitial cystitis/painful bladder syndrome and controls in relation to potentially related conditions,...

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Evidence suggests that gut flora may play an important role in the pathophysiology of the irritable bowel syndrome (IBS). We evaluated rifaximin, a minimally absorbed antibiotic, as treatment for IBS.

Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.

Probiotic agents have received growing attention in recent years as an alternative therapeutic tool in the management of irritable bowel syndrome. In this article, we will discuss the rationale that s...

Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case-control study.

PURPOSE: The diagnosis of irritable bowel syndrome is symptom based, and colonoscopy is the most direct way to rule out organic colonic diseases. It is controversial on the necessity of colonoscopy fo...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement